Abstract 411P
Background
The cancer, which claims a million deaths per annum across India is a major concern due to presentation in later stages, owing to lack of awareness and structured screening programs. The fragmented screening happens through hospitals (HBS), rural camps by screening buses (CSB), awareness programs, and augmented self-examination (ASE) protocols using AI. This research is aimed to empower cancer screening strategies.
Methods
The effective analysis is based on the number of cancer cases detected and treated effectively. Cost data were collected as a combination of CAPEX and OPEX to do a camp and cost is derived per test using key informant interviews, patient surveys, and other publicly available data sources. A hypothetical cohort of 5,00,000 patients was assumed for assessing each strategy. One-way, two-way, and probabilistic sensitivity analyses were performed to test the robustness of the result. The methods selected were HBS, CSB &ASE.
Results
The results showed augmented self-examination is the best strategy followed by education and lastly screening vehicles. One-way analysis showed that the results were sensitive to the labor cost, but the two-way analysis showed that results are not sensitive to cancer burden. The cost of ASE for 3 cancers (oral, cervical breast) per person is INR 150, for CSB 1200 INR, and for HBS its 650 INR.
Conclusions
ASE is the way forward in developing nations followed by empowering the community health centers and the least effective is cancer screening buses.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
420P - Predictive factors of post-operative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study
Presenter: Chito Cabiling
Session: Poster viewing 06
421P - The association between early changes in neutrophil-lymphocyte ratio and survival in patients treated with immunotherapy
Presenter: Deniz Can Guven
Session: Poster viewing 06
422P - Molecular mechanism in prostate cancer with TP53 mutation
Presenter: Bin Hu
Session: Poster viewing 06
423P - Maintaining a national essential medicine list for cancer in Malaysia: Where do we stand?
Presenter: David Lee
Session: Poster viewing 06
424P - The Storm: Paraneoplastic leucomoid reaction - A bad prognostic factor
Presenter: Abdullah Al Mamun Khan
Session: Poster viewing 06
425P - Preliminary study: Assessment of public trust in traditional medicine and medical treatment in cancer patients in Indonesia - Study validity and reliability of the Universitas Sebelas Maret Trust and readiness assessment for cancer patients (UNS – TRAfCP35) questionnaire
Presenter: Widyanti Soewoto
Session: Poster viewing 06
426P - Safety of Sputnik V COVID-19 vaccine in cancer patients receiving chemotherapy: An observational study
Presenter: Alexey Rumyantsev
Session: Poster viewing 06
427P - Oncology combination therapies in Asia-Pacific markets: What are the current access challenges?
Presenter: Gayathri Kumar
Session: Poster viewing 06
428P - Clinical characteristics, laboratory parameters, and hospital outcomes of COVID-19 among patients with and without cancer: A retrospective cohort study
Presenter: PRASHANT SIROHIYA
Session: Poster viewing 06
429P - Cancer and COVID-19 in India: Assessing the impact in a nationwide survey
Presenter: Bharti Devnani
Session: Poster viewing 06